# US 2023/0266209 A1 · Manipulating and detecting biological samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2023/0266209 A1
- Document ID: US20230266209A1
- Status: Published application
- Kind: A1
- Application number: 18/309,116
- Filed: 2023-04-28
- Published: 2023-08-24
- Earliest claimed: 2021-10-25
- Assignees: Singular Genomics Systems, Inc.
- Applicants: Singular Genomics Systems, Inc.
- Inventors: Jaekyung KOH; Zhenmin HONG; Weiqiao DING; Hu CANG; William DEMPSEY; Eli N. GLEZER; Yuji ISHITSUKA; Mohammad Vatankhah VARNOSFADERANI
- Web page: https://patentgrep.com/patent/US20230266209A1

## CPC

- G01N 1/30: Staining; Impregnating {; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis}
- G06V 20/69: Microscopic objects, e.g. biological cells or cellular parts
- C12N 1/08: Reducing the nucleic acid content
- C12Q 1/37: involving peptidase or proteinase
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C12Q 1/6825: Nucleic acid detection involving sensors
- C12Q 1/6834: Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q 1/6841: In situ hybridisation
- C12Q 1/6844: Nucleic acid amplification reactions
- C12Q 1/6874: involving nucleic acid arrays, e.g. sequencing by hybridisation
- G01N 1/06: providing a thin slice, e.g. microtome
- G01N 1/28: Preparing specimens for investigation {including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q}(mounting specimens on microscopic slides G02B21/34; means for supporting the objects or the materials to be analysed in electron microscopes H01J37/20 {; laboratory gas handling apparatus B01L5/00})
- G01N 1/286: {involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising (microtomes G01N1/06; pulverising in general B02C; mixing in general B01F)}
- G01N 1/312: {for samples mounted on planar substrates}
- G01N 1/36: Embedding or analogous mounting of samples
- G01N 23/2251: using incident electron beams, e.g. scanning electron microscopy [SEM]
- G01N 33/582: {with fluorescent label}
- G02B 21/34: Microscope slides, e.g. mounting specimens on microscope slides
- G01N 2001/2873: {Cutting or cleaving}
- G01N 2001/288: {Filter punches}
- G01N 2001/315: {Basket-type carriers for tissues}
- G06V 2201/031: of internal organs
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- G06V: IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G02B: OPTICAL ELEMENTS, SYSTEMS OR APPARATUS

## Abstract

Disclosed herein, inter alia, are compositions and methods for efficient transfer and analyses of cellular material, tissue samples, such as tissue sections, using carrier substrates.

## Claims

### Claim 1

A method of detecting a biomolecule in a tissue section, said method comprising:
a) contacting the tissue section with a carrier substrate, thereby immobilizing the tissue section onto said carrier substrate and generating a sample-carrier construct, wherein said carrier substrate comprises a first adhesion strength;
b) contacting the tissue section of the sample-carrier construct with a receiving substrate to generate an immobilized tissue section, wherein said receiving substrate comprises a second adhesion strength, wherein the second adhesion strength is greater than the first adhesion strength;
c) removing the carrier substrate from the immobilized tissue section;
d) permeabilizing the immobilized tissue section; and
e) contacting said biomolecule in said tissue section with a detection agent, thereby detecting the biomolecule in the tissue section, wherein the detection agent comprises a fluorophore.

### Claim 2 (depends on 1)

The method of claim 1, wherein step c) occurs prior to step e).

### Claim 3 (depends on 1)

The method of claim 1, wherein step c) occurs prior to step d).

### Claim 4 (depends on 1)

The method of claim 1, wherein generating a sample-carrier construct comprises forming a plurality of non-covalent bonds between the tissue section and the carrier substrate.

### Claim 5 (depends on 1)

The method of claim 1, wherein the carrier substrate comprises water molecules attached to the surface of said carrier substrate.

### Claim 6 (depends on 1)

The method of claim 1, wherein the carrier substrate comprises a compression modulus greater than about 100 kPa.

### Claim 7 (depends on 1)

The method of claim 1, wherein generating an immobilized tissue section comprises forming a plurality of covalent bonds between the tissue section and the receiving substrate.

### Claim 8 (depends on 1)

The method of claim 1, wherein the receiving substrate comprises (3-aminopropyl)triethoxysilane (APTES), (3-Aminopropyl)trimethoxysilane (APTMS), γ-Aminopropylsilatrane (APS), N-(6-aminohexyl)aminomethyltriethoxysilane (AHAMTES), polyethylenimine (PEI), 5,6-epoxyhexyltriethoxysilane, or triethoxysilylbutyraldehyde, or a combination thereof.

### Claim 9 (depends on 1)

The method of claim 1, wherein the biomolecule is a nucleic acid sequence, carbohydrate, or protein.

### Claim 10 (depends on 1)

The method of claim 1, wherein the biomolecule is a nucleic acid sequence.

### Claim 11 (depends on 10)

The method of claim 10, further comprising amplifying the nucleic acid sequence to generate amplification products.

### Claim 12 (depends on 11)

The method of claim 11, further comprising detecting the amplification products.

### Claim 13 (depends on 1)

The method of claim 1, wherein the detection agent comprises a protein-specific binding agent.

### Claim at position 14

-15. (canceled)

### Claim 16 (depends on 1)

The method of claim 1, further comprising digesting the tissue section by contacting the sample-carrier construct with an endopeptidase.

### Claim 17 (depends on 10)

The method of claim 10, wherein step e) comprises hybridizing a sequencing primer to the biomolecule and sequencing the biomolecule.

### Claim at position 17

-24. (canceled)

### Claim 25 (depends on 1)

The method of claim 1, wherein the thickness of the tissue section is about 1 μm to about 20 μm.

### Claim 26 (depends on 1)

The method of claim 1, wherein the carrier substrate comprises agarose, amylose, amylopectin, alginate, gelatin, cellulose, polyolefin, polyethylene glycol, polyvinyl alcohol, and/or acrylate polymers and copolymers thereof.

### Claim 27 (depends on 1)

The method of claim 1, wherein the carrier substrate comprises agarose, amylose, or amylopectin.

### Claim 28

(canceled)

### Claim 29 (depends on 1)

The method of claim 1, wherein the carrier substrate further comprises a support scaffold, wherein said support scaffold is a thermoplastic elastomer.

### Claim 30 (depends on 1)

The method of claim 1, wherein the carrier substrate comprises a Young's modulus of about 5 kPa to about 30 kPa.

### Claim 31

(canceled)

### Claim 32 (depends on 1)

The method of claim 1, wherein the carrier substrate comprises about 80% to about 99% water.

### Claim 33 (depends on 1)

The method of claim 1, wherein the receiving substrate comprises a functionalized glass surface or a functionalized plastic surface.

### Claim 34 (depends on 1)

The method of claim 1, wherein prior to contacting the tissue section with the receiving substrate, the sample-carrier construct is stored for one or more days.

### Claim at position 28

-36. (canceled)

### Claim 37 (depends on 34)

The method of claim 34, wherein the sample-carrier construct is stored at less than about 25° C.

### Claim at position 30

-39. (canceled)

### Claim 40 (depends on 1)

The method of claim 1, wherein removing the carrier substrate comprises physically removing, thermally removing, chemically removing, or enzymatically removing.

### Claim at position 32

-98. (canceled)

### Claim 99 (depends on 1)

The method of claim 1, wherein the sample-carrier construct comprises substantially uniform adhesion between the tissue section and the carrier substrate.

### Claim 100 (depends on 1)

The method of claim 1, wherein the carrier substrate comprises a polymerized hydrogel.

### Claim 101 (depends on 1)

The method of claim 1, wherein substantially all of the tissue section is immobilized to the receiving substrate.

### Claim 102 (depends on 1)

The method of claim 1, wherein prior to step a), the carrier substrate is solid or semi-solid.

### Claim 103 (depends on 40)

The method of claim 40, wherein physically removing said carrier substrate comprises mechanically pulling or lifting thereby detaching said carrier substrate.
